Ephx2 Antibody

Code CSB-PA007735XA01RA
Size Enquire
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Rattus norvegicus (Rat) Ephx2 Polyclonal antibody
Uniprot No.
Target Names
Ephx2
Alternative Names
Ephx2 antibody; Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 antibody; CEH antibody; EC 3.3.2.10 antibody; Epoxide hydratase antibody; Soluble epoxide hydrolase antibody; SEH); Lipid-phosphate phosphatase antibody; EC 3.1.3.76)] antibody
Raised in
Rabbit
Species Reactivity
Rattus norvegicus (Rat)
Immunogen
Recombinant Rattus norvegicus (Rat) Ephx2 protein
Immunogen Species
Rattus norvegicus (Rat)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, WB (ensure identification of antigen)
Protocols
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Value-added Deliverables
① 200ug * antigen (positive control);
② 1ml * Pre-immune serum (negative control);
Quality Guarantee
① Antibody purity can be guaranteed above 90% by SDS-PAGE detection;
② ELISA titer can be guaranteed 1: 64,000;
③ WB validation with antigen can be guaranteed positive;
Lead Time
Made-to-order (14-16 weeks)

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid and 12-phosphonooxy-octadec-9E-enoic acid.; Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators.; Bifunctional enzyme. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid and 12-phosphonooxy-octadec-9E-enoic acid. Has phosphatase activity toward lyso-glycerophospholipids with also some lower activity toward lysolipids of sphingolipid and isoprenoid phosphates.
Gene References into Functions
  1. Data suggest that significant dietary potassium (here, even as a single meal) increases postprandial effects that reduce sEH activity in blood by mechanisms involving insulin secretion and gut microbiota; these mechanisms combat oxidative stress and prevent cardiovascular diseases. PMID: 28863368
  2. Prophylactic treatment with sEH inhibitors decreased myocardial damage due to ischemia reperfusion, hypertension and diabetes, and decreased endothelial dysfunction created by diabetes and hypertension. PMID: 28296232
  3. Potent natural soluble epoxide hydrolase inhibitors from Pentadiplandra brazzeana baillon: synthesis, quantification, and measurement of biological activities in vitro and in vivo. PMID: 25659109
  4. The results suggest Ephx2 participation in the control of the vascular tone changes in kidney promoting the hypertensive state in the ISIAH rats. PMID: 25509856
  5. Soluble epoxide hydrolase probably plays an important role in the development of hypertension in the rat models of renovascular hypertension. The activation of PPAR-gamma and RAAS by renal arterial stenosis are associated with sEH upregulation. PMID: 22178827
  6. Inhibition of soluble epoxide hydrolase slows the progression of hyperglycemia and provides cardioprotection. PMID: 22865388
  7. Programmed blood pressure-lowering effects of perinatal SEH inhibition cannot be only explained by persistent reduction in renal SEH activity but rather by more complex interactions between the renal SEH, lipoxygenase, and cyclooxygenase pathways. PMID: 21266668
  8. Epoxide hydrolase inhibitors displays antihypertensive effects in Ren-2 transgenic rats with inducible malignant hypertension via an improvement of renal function. PMID: 21078594
  9. Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation. PMID: 21164107
  10. Soluble epoxide hydrolase enzyme (SEH) inhibition or Ephx2 gene deletion antagonizes neointimal formation in vivo by mechanisms that are endothelium dependent. SEH inhibition may have therapeutic potential for flow-induced remodeling. PMID: 20035028
  11. Epoxide hydrolase plays a role in the regulation of blood pressure PMID: 11882632
  12. Polymorphism in Ephx2 is not likely to contribute to blood pressure levels in spontaneously hypertensive rats. PMID: 12364351
  13. AP-1 activation is involved in the transcriptional up-regulation of sEH by angiotensin II (Ang II) in endothelial cells, which may contribute to Ang II-induced hypertension PMID: 17495027
  14. Linkage analyses with genome-wide expression profiling identified Ephx2 as a heart failure susceptibility gene in SHHF rats. PMID: 18443590
  15. protein level of sEH was elevated in the heart of both spontaneously hypertensive rats and Ang II-infused Wistar rats PMID: 19126686

Show More

Hide All

Subcellular Location
Cytoplasm. Peroxisome.
Protein Families
AB hydrolase superfamily, Epoxide hydrolase family
Database Links
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1